Involvement of hypothalamic neuropeptide Y in regulating the amphetamine-induced appetite suppression in streptozotocin diabetic rats.

Department of Physiology, Chung Shan Medical University, Taichung 40201, Taiwan, ROC.
Regulatory Peptides (Impact Factor: 2.06). 05/2005; 127(1-3):19-26. DOI: 10.1016/j.regpep.2004.10.008
Source: PubMed

ABSTRACT Amphetamine (AMPH) is a well-known anorectic agent. In normal rats, AMPH-induced anorexia has been attributed to its inhibitory action on hypothalamic neuropeptide Y (NPY), an appetite stimulant in the brain. In diabetic rats, however, if this anorectic response of AMPH might still be observed was uncertain.
Rats (including normal, diabetic and insulin-treated diabetic rats) were given daily with saline or AMPH for 6 days. Changes in food intake, plasma glucose level (PGL) and NPY content of these rats were measured and compared.
The AMPH-induced anorectic response was altered in diabetic rats. Although the anorectic effects of AMPH on the first day of dosing were similar between diabetic and control rats, diabetic rats developed tolerance to this anorexia more rapidly than control rats. This alteration was independent of PGL since PGL levels were not changed following AMPH treatment and PGL normalization induced by phlorizin could not restore the level of AMPH anorexia. On the other hand, this alteration was dependent on the action of NPY because NPY contents were decreased following AMPH treatment and the replacement of insulin in diabetic rats could restore both NPY content and AMPH anorexia.
These results suggested that the elevated hypothalamic NPY content in diabetic rats was involved in modifying the anorectic response of AMPH.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Amphetamine (AMPH), a psychostimulant, is an appetite suppressant and may be regarded as a neurotoxin. It was reported that superoxide dismutase (SOD) and neuropeptide Y (NPY) participated in AMPH-mediated behavior response. However, molecular mechanisms underlying this action are not well known. Using feeding behavior as an indicator, this study investigated if protein kinase C (PKC)-delta signaling was involved. Rats were given daily with AMPH for 4 days. Changes in hypothalamic NPY, PKCdelta and SOD mRNA contents were measured and compared. Results showed that the up-regulations of PKCdelta and SOD mRNA levels following AMPH treatment were concomitant with the down-regulation of NPY mRNA level and the decrease of feeding. To further determine if PKCdelta was involved, intracerebroventricular infusions of PKCdelta antisense oligonucleotide were performed at 1h before daily AMPH treatment in freely moving rats, and results showed that PKCdelta knock-down could block the anorectic response and restore partially both NPY and SOD mRNA levels in AMPH-treated rats. It is suggested that central PKCdelta signaling may play a functional role in the regulation of AMPH-mediated appetite suppression via a modification of hypothalamic NPY gene expression. Moreover, the increase of SOD during AMPH treatment may favor this modification.
    Chemico-biological interactions 08/2009; 180(2):193-201. · 2.46 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In this study, the effects of peripheral (intraperitoneal) injections of D-amphetamine on feeding behavior were assessed in goldfish. Compared with the saline-injected group, amphetamine injections decreased food intake at doses ranging from 1 to 75 μg/g, but not 0.5 μg/g, but increased locomotor behavior, as indicated by the increased number of total feeding and non-feeding acts, at doses ranging from 2.5 to 25 μg/g. Amphetamine at high doses inhibited both food intake (at 25, 50 and 75 μg/g) and feeding behavior (at 75 μg/g). In the hypothalamus, the expression of orexin was down-regulated, and both CART 1 and CART 2 expressions were up-regulated in amphetamine-treated fish (50 μg/g) as compared to saline-injected fish, but amphetamine treatment had no effect on either hypothalamic TH or TRH expression. In the telencephalon, amphetamine treatment (50 μg/g) up-regulated CART 1, CART 2 and TH mRNA expressions but had no effect on either orexin or TRH. Our results suggest that, as in mammals, the orexin, CART and TH systems might be involved in amphetamine-induced feeding/locomotor responses in goldfish.
    Fish Physiology and Biochemistry 12/2012; · 1.55 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background and PurposeAmphetamine (AMPH)-induced appetite suppression has been attributed to its inhibition on neuropeptide Y (NPY) neurons and activation on proopiomelanocortin (POMC) neurons in the hypothalamus. This study examined whether signal transducer and activator of transcription-3 (STAT3) was involved in AMPH's action. Experimental ApproachRats were given AMPH daily for four days. Changes in the expression of NPY, POMC, melanocortin receptor 3 (MC3R), phosphatidylinositol 3-kinase (PI3K), and STAT3 were assessed and compared. Key ResultsResults showed that the expression of NPY decreased with the biggest reduction on Day 2 during AMPH treatment. Alternatively, the expression of POMC, MC3R, PI3K, and STAT3 increased with a maximum response on Day 2. Moreover, pSTAT3/DNA binding activity increased and was expressed in a pattern similar to POMC, MC3R, and PI3K expression. The intracerebroventricular infusion of STAT3 antisense was performed at 60 min before AMPH treatment. This infusion could partially block AMPH-induced anorexia and modulate the expression of NPY, POMC, MC3R, and PI3K, indicating the involvement of STAT3 in AMPH-treated rats. Conclusions and ImplicationsThe results suggest that hypothalamic PI3K-STAT3 signalling participates in regulating NPY- and POMC-mediated appetite suppression and may advance the medical research of anorectic drugs.
    British Journal of Pharmacology 03/2014; · 5.07 Impact Factor